HGSI Related Guidance
-
Human Genome Sciences (HGSI) Misses Q3 EPS by 6c; Cuts Cash, Investments View
-
Human Genome (HGSI) to Update on BENLYSTA; Guides R&D and SG&A Expense for FY11
-
Human Genome (HGSI) Updates on Expectations Heading into 2011
-
Human Genome Sciences (HGSI) Substantial Progress Toward Commercialization
-
Human Genome Sciences (HGSI) Updates Recent Collaborations, Contracts and Financial Outlook
-
Human Genome (HGSI) Reports Q2 Loss; Guides Below
Back to HGSI Stock Lookup
